ZJCK-6-46
Product Specifications
UNSPSC Description
ZJCK-6-46 (32) is a potential and orally activeDYRK1A inhibitor (IC50 = 0.68 nM) with high BBB permeability (CNS+). ZJCK-6-46 (32) reduces tau phosphorylation. ZJCK-6-46 (32) ameliorates cognitive dysfunction by obviously reducing the expression of phosphorylated tau and neuronal loss in vivo[1].
Target Antigen
DYRK; Tau Protein
Type
Reference compound
Related Pathways
Neuronal Signaling;Protein Tyrosine Kinase/RTK
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zjck-6-46.html
Smiles
CC1=NC2=C(C=C1)C(C3=CC4=C(C=C3)N=CN=C4N[C@@H](C5=CC=CC=C5)CO)=CN2
Molecular Weight
395.46
References & Citations
[1]Huanhua Chen, et al. Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease. J Med Chem. 2024 Aug 8;67(15):12571-12600.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162750/ZJCK-6-46-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162750/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1376314-01 0.02 mg (E-Coli)
Recombinant Picrophilus torridus Isopentenyl-diphosphate delta-isomerase (fni)
Ask
View Details